Skip to main content
. 2019 May 9;14(5):e0216621. doi: 10.1371/journal.pone.0216621

Table 2. Prion detection in tissue harvested from a mouse dilutional bioassay of CWD+ cervid brain.

Mouse cohort
(average dpi to terminal disease ± SD)
n+/total n
Tissue tested Assay 10−2 CWD (203±36) 10−3 CWD (239±46) 10−4 CWD (232±54) 10−5 CWD (372±133) 10−6 CWD (423±108) 10−7 CWD (>450) Neg
(NA)
Brain WB 6/6 6/6 5/6 2/5 2/5 0/6 0/12
IHC 6/6 6/6 5/6 3/5 2/5 0/6 0/12
sPMCA/
WB
5/5 6/6 5/6 2/5 2/5 0/6 0/12
RT-QuIC 5/5 6/6 5/6 3/5 2/5 0/6 0/12
sPMCA/
RT-QuIC
5/5 6/6 6/6 3/5 2/5 0/6 0/12
Spleen RT-QuIC 5/5 6/6 5/6 3/5 2/5 0/6 0/12

Comparison of in vitro conventional (WB, IHC) and amplification (RT-QuIC, sPMCA/WB and sPMCA/RT-QuIC) assays. Prions were detected in the brains of mice inoculated with CWD+ cervid brain (CBP6) dilutions 10−2–10−6 (300 μg-30 ng) by all assays. sPMCA/RT-QuIC detected prions in brain tissue of one additional mouse in the 10−4 cohort (3 μg seed material). In the 10−5 cohort, IHC, RT-QuIC, sPMCA/RT-QuIC and RT-QuIC of spleen tissue revealed one additional prion+ mouse than WB and sPMCA/WB. Prions were not detected in mice inoculated with the 10−7 CBP6 dilution (3 ng) nor in n = 12 negative control mice inoculated with naïve cervid brain homogenate.